Совершенствование методов противорецидивного лечения больных мочекаменной болезнью с использованием минеральной воды курорта иссык-ата (стр. 17 )

156.  Brikowski, T. H. Climate-related increase in the prevalence of urolithiasis in the United States [Text] / T. H. Brikowski, Y. Lotan, M. S. Pearle // Proc. Natl. Acad. Sci. USA. – 2008. – Vol. 105, # 28. – P. 9841-9846.

157.  Calcium oxalate aggregation in whole urine, new aspects of calcium stone formation and metaphylaxis [Text] / [J. M. Baumann, B. Affolter, U. Carpez et al.] // Fur. Urol. – 2003. – Vol. 43, # 4. – P. 421-425.

158.  Cameron, M. A. Nephrolithiasis in children [Text] / M. A. Cameron, K. Sakhaee, O. W. Moe // Pediatr. Nephrol. – 2005. – Vol. 20, # 11. – P. 1587-1592.

159.  Caudarella, R. Renal stone formation in patients with inflammatory bowel disease [Text] / R. Caudarella, E. Rizzoli, L. Pironi // Scanning. Microscopy. – 1993. – Vol. 7, # 1. – P. 371-379.

160.  Caudarella, parative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis [Text] / R. Caudarella, E. Rizzoli, A. Buffa // J. Urol. – 1998. – Vol. 159. – P. 658-663.

161.  Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women [Text] / [G. C. Curhan, W. C. Willett, F. E. Spiegelman et al.] // Ann. Intern. Med. – 1997. – Vol. 126, # 7. – P. 497-504.

162.  Corbetta, S. Risk factors associated to kidney stones in primary hyperparathyroidism [Text] / S. Corbetta, A. Baccarelli, A. Aroldi // J. Endocrinol. Invest. – 2005. – Vol. 28, # 2. – P. 122-128.

163.  Delakas, D. Management of ureteral stones in pediatric patients [Text] / D. Delakas, G. Daskalopoulus, M. Metaxari // J. Endourol. – 2001. – Vol. 15, # 7. – P. 675-680.

164.  Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline [Text] / [M. Straub, W. L. Strohmaier, W. Berg et al.] // World J. Urol. – 2005. – Vol. 23, # 5. – P. 309-323.

165.  Diagnostik der enteralen Oxalathy pesabsorption dlei Paienten mit idiopathischem rezidivierendem kalziumoxalatharusteinleigen [Text] / [W. Berg, R. Haerting, C. Bothor et al.] // Urologe. – 1990. – B. 229, H. 2. – S. 148-151.

166.  Epidemiology of kidney stones in Iceland: a population-based study [Text] / [O. S. Indridason, S. Birgisson, V. O. Edvardsson et al.] // Scand. J. Urol. Nephrol. – 2009. – Vol. 40, # 3. – P. 215-220.

167.  Fan, Y. A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial [Text] / Y. Fan, S. Chen, Y. Yu // J. Zhejiang. Univ. SCIENCE. – 2006. – Vol. 7, # 12. – P. 987-991.

168.  Galvin, D. J. The contemporary management of renal and ureteric calculi [Text] / D. J. Galvin, M. S. Pearle // BJU Int. – 2006. – Vol. 98, # 6. – P. 1283-1288.

169.  Gillen, D. L. Nephrolithiasis and increased blood pressure among females with high body mass index [Text] / D. L. Gillen, F. L. Coe, E. M. Worcester // Am. J. Kidney Dis. – 2005. – Vol. 20. – P. 263-269.

170.  Hamilton-Miller, J. M. The role of probiotios in the treatment and prevention of Helocobacter pylori infection [Text] / J. M. Hamilton-Miller // Int. J. Antimicrob. Agents. -2003. – Vol. 22, # 2. – P. 360-366.

171.  Hesse, A. Urinary stones: diagnosis, treatment and prevention of recurrence [Text] / A. Hesse, H. G. Tiselius, A. Jahnen // Uric acid stones. Basel: Karger, 2002. – P. 73-91.

172.  Hosking, D. Y. The stone clinic effect in patients with idiopathic calcium urolithiasis [Text] / D. H. Hosking, S. B. Erickson // J. Urol. – 1983. – Vol. 130. – P. 1115-1118.

173.  Karsli, O. Metabolic risk factors and the effect of metaphylazis in pediatric stone disease with hypocitraturia [Text] / O. Karsli, V. Izol, I. A. Aridogan // Urolithiasis. – 2013. – Vol. 41, # 1. – P. 9-13.

174.  Kmuilcik, J. Diagnostic, prophylaxsis and treatment of urolithiasis [Text] / J. Kmuilcik // Pzzegl. Lek. – 1997. – Vol. 54, # 5. – P. 335-343.

175.  Knoll, T. Epidemiology, pathogenesis and pathophysiology of urolithiasis [Text] / T. Knoll // Eur. ppl. – 2010. – Vol. 9. – P. 802-806.

176.  Kocvara, R. A prospective study of nonmedical prophylaxis after a first kidney stone [Text] / R. Kocvara, P. Plasgura, A. Petrik // Br. J. Urol. Int. – 1999. - # 4. – P. 393-398.

177.  Kohrmann, K. U. Guidelines on diagnostic, therapy and metaphylaxis of urolithiasis [Text] / K. U. Kohrmann, T. Knoll, C. Chaussy // Urologe A. – 2009. – Vol. 48, # 9. – P. 1084-1093.

178.  Lahme, S. Significance of “clinically insignificant residual fragments” (CIRF) after ESWE [Text] / S. Lahme, D. M. Wilbert, K. H. Bichler // Urologe. 0 1997. – Vol. 36, # 3. – P. 226-230.

179.  Long-term stone recurrence rate after extracorporeal shock wave lithotripsy [Text] / [O. Kamihira, Y. Ono, N. Katoh et al.] // J. Urol. – 1996. – Vol. 156, # 4. – P. 1267-1271.

180.  Medical reduction of stone risk in a network of treatment centers compared to research clinic [Text] / [J. E. Lingeman, H. Mardis, R. Kahnowski et al.] // J. Urol. (Baltimore). – 1998. – Vol. 160, # 5. – P. 1629-1634.

181.  Meissner, A. Urinary tract infections and urolithiasis [Text] / A. Meissner, C. Mamoulakis, N. Laube // Urologe A. – 2010. – Vol. 49, # 5. – P. 623-628.

182.  Menditto, V. G. Metaphylaxis of urolithiasis [Text] / V. G. Menditto, G. Milanese, G. Muzzonigro // Arch. Ital. Urol. Androl. – 2009. – Vol. 81, # 1. – P. 32-39.

183.  Meneses, J. A. The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients [Text] / J. A. Meneses, E. M. Lucas, F. C. Assuneao // Urol. Res. – 2012. – Vol. 40, # 3. – P. 225-229.

184.  Miller, N. L. Management of kidney stones [Text] / N. L. Miller, J. E. Lingeman // BMJ. – 2007. – Vol. 334, # 7591. – P. 468-472.

185.  Natural history of residual renal stone fragments after ESWL [Text] / [C. Candau, C. Saussine, H. Lang et al.] // Eur. Urol. – 2000. – Vol. 37, # 1. – P. 18-22.

186.  New aspects of urolithiasis in France [Text] / [R. Donsimoni, C. Hennequin, S. Fellahi et al.] // Eur. Urol. – 1997. – Vol. 31, # 1. – P. 17-23.

187.  Pak, C. Y.C. Role of medical prevention [Text] / C. Y.C. Pak // J. Urol. (Baltimore). – 1989. – Vol. 141. – P. 798-801.

188.  Possible relationship between metabolic syndrome traits and nephrolithiasis: Incidence for 15 years according to gender [Text] / [I. H. Chang, K. D. Kim, Y. T. Moon et al.] // Korean J. Urol. – 2011. – Vol. 52, # 8. – P. 548-553.

189.  Romero, V. Kidney stones: A global picture of prevalence, incidence and associated risk factors [Text] / V. Romero, H. Akpinar, D. G. Assimos // Rev. Urol. – 2010. – Vol. 12, # 2-3. – P. 86-96.

190.  Siener, R. Recurrence prevention of urolithiasis with respect to economic aspects [Text] / R. Siener, N. Laube, W. L. Strohmaier // Urologe. – 2011. – Vol. 50, # 10. – P. 1278-1282.

191.  Straub, M. Pediatric urolithiasis: the current surgical management [Text] / M. Straub, J. Gschwend, C. Zorn // Pediatr. Nephrol. – 2010. – Vol. 25, # 7. – P. 1239-1244.

192.  Taylor, E. N. Obesity, weight gain, and risk of kidney stones [Text] / E. N. Taylor, M. J. Stampfer, G. C. Curan // JAMA. – 2005. – Vol. 293, # 4. – P. 455-462.

193.  Tiselius, H.-G. Factors influencing the course of calcium oxalate stone disease [Text] / H. G. Tiselius // Eur. Urol. – 1999. – Vol. 36, # 5. – P. 363-370.

194.  Tiselius, H-G. Guidelines on urolithiasis [Text] / H. G. Tiselius, D. Ackermann, P. Alken // EAU. – 2002. – Vol. 12. – P. 217-220.

195.  Tiselius, H.-G. Epidemiology and medical management of stone disease [Text] / H.-G. Tiselius // BJU International. – 2003. – Vol. 91, Issue 8. – P. 758-767.

196.  Trinchieri, A. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone [Text] / A. Trinchieri, F. Ostini, R. Nespoli // J. Urol. (Baltimore). – 1999. – Vol. 162, # 1. – p. 27-30.

197.  Trinchieri, A. Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years [Text] / A. Trinchieri, F. Coppi, E. Montanari // Eur. Urol. – 2000. – Vol. 37. - P. 23-25.

198.  Urine colume: Stone risk factor and preventive measure [Text] / [I. Borghi, T. Meschi et al.] // Nephron. – 1999. – Vol. 81 (suppl. 1). – P. 31-37.

199.  Wen, C. C. Treatment selection and outcomes: renal calculi [Text] / C. C. Wen, S. Y. Makada // Urol. Clin. North Am. – 2007. – Vol. 34, # 3. – P. 409-419.